Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hemmer

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Clinical Neuroradiology|February 15, 2020
T1-Weighted Intensity Increase After a Single Administration of a Linear Gadolinium-Based Contrast Agent in Multiple SclerosisS Grahl, M Bussas, V Pongratz, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 1, 2020
Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis PatientsM C Kowarik, D Astling, G Lepennetier, et al.
The Annals of Thoracic Surgery|October 16, 2012
The David procedure in different valve pathologies: a single-center experience in 236 patientsMarkus Liebrich, Marcin K Kruszynski, Detlev Roser, et al.
Journal of Neuroimmunology|June 4, 2005
Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosisA Kroner, F Vogel, A Kolb-Mäurer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homologyB Hemmer, M Vergelli, B Gran, et al.
Neurology|September 16, 2009
Interferon beta treatment does not induce organ-specific autoantibodies in multiple sclerosisT Menge, N C Schloot, M Schott, et al.
Journal of Neuroimmunology|July 22, 1998
Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clonesD Reinhold, B Hemmer, B Gran, et al.
Autoimmunity|June 25, 2003
CD45 isoform expression in autoimmune myasthenia gravisB Tackenberg, M Nitschke, N Willcox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potencyB Hemmer, C Pinilla, B Gran, et al.
Brain : a Journal of Neurology|October 24, 2001
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosisS Cepok, M Jacobsen, S Schock, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Clinical Neuroradiology|February 15, 2020
T1-Weighted Intensity Increase After a Single Administration of a Linear Gadolinium-Based Contrast Agent in Multiple SclerosisS Grahl, M Bussas, V Pongratz, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 1, 2020
Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis PatientsM C Kowarik, D Astling, G Lepennetier, et al.
The Annals of Thoracic Surgery|October 16, 2012
The David procedure in different valve pathologies: a single-center experience in 236 patientsMarkus Liebrich, Marcin K Kruszynski, Detlev Roser, et al.
Journal of Neuroimmunology|June 4, 2005
Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosisA Kroner, F Vogel, A Kolb-Mäurer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homologyB Hemmer, M Vergelli, B Gran, et al.
Neurology|September 16, 2009
Interferon beta treatment does not induce organ-specific autoantibodies in multiple sclerosisT Menge, N C Schloot, M Schott, et al.
Journal of Neuroimmunology|July 22, 1998
Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clonesD Reinhold, B Hemmer, B Gran, et al.
Autoimmunity|June 25, 2003
CD45 isoform expression in autoimmune myasthenia gravisB Tackenberg, M Nitschke, N Willcox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potencyB Hemmer, C Pinilla, B Gran, et al.
Brain : a Journal of Neurology|October 24, 2001
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosisS Cepok, M Jacobsen, S Schock, et al.
Pageof 14